SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    W. Boesmans, C. Cirillo, V. Van den Abbeel, C. Van den Haute, I. Depoortere, J. Tack, P. Vanden Berghe, Neurotransmitters involved in fast excitatory neurotransmission directly activate enteric glial cells, Neurogastroenterology & Motility, 2013, 25, 2
  2. 2
    Frank Reimann, Gwen Tolhurst, Fiona M. Gribble, G-Protein-Coupled Receptors in Intestinal Chemosensation, Cell Metabolism, 2012, 15, 4, 421

    CrossRef

  3. 3
    I. M. Hons, M. A. Storr, K. Mackie, B. Lutz, Q. J. Pittman, G. M. Mawe, K. A. Sharkey, Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling, Neurogastroenterology & Motility, 2012, 24, 3
  4. 4
    Raquel Abalo, Gema Vera, Ana Esther López-Pérez, María Martínez-Villaluenga, María Isabel Martín-Fontelles, The Gastrointestinal Pharmacology of Cannabinoids: Focus on Motility, Pharmacology, 2012, 90, 1-2, 1

    CrossRef

  5. 5
    R. Abalo, P. A. Cabezos, G. Vera, V. López-miranda, E. Herradón, M. I. Martín-fontelles, Cannabinoid-induced delayed gastric emptying is selectively increased upon intermittent administration in the rat: role of CB1 receptors, Neurogastroenterology & Motility, 2011, 23, 5
  6. 6
    E. Scarpellini, K. Blondeau, V. Boecxstaens, R. Vos, A. Gasbarrini, R. Farré, J. Tack, Effect of rimonabant on oesophageal motor function in man, Alimentary Pharmacology & Therapeutics, 2011, 33, 6
  7. You have free access to this content7
    V. Di Marzo, F. Piscitelli, Gut feelings about the endocannabinoid system, Neurogastroenterology & Motility, 2011, 23, 5
  8. 8
    Werend Boesmans, Grzegorz Owsianik, Jan Tack, Thomas Voets, Pieter Vanden Berghe, TRP channels in neurogastroenterology: opportunities for therapeutic intervention, British Journal of Pharmacology, 2011, 162, 1
  9. 9
    Angelo A. Izzo, Keith A. Sharkey, Cannabinoids and the gut: New developments and emerging concepts, Pharmacology & Therapeutics, 2010, 126, 1, 21

    CrossRef

  10. You have free access to this content10
    M. A. Storr, M. Bashashati, C. Hirota, V. K. Vemuri, C. M. Keenan, M. Duncan, B. Lutz, K. Mackie, A. Makriyannis, W. K. Macnaughton, K. A. Sharkey, Differential effects of CB1 neutral antagonists and inverse agonists on gastrointestinal motility in mice, Neurogastroenterology & Motility, 2010, 22, 7
  11. 11
    Rudolf Schicho, Martin Storr, Targeting the endocannabinoid system for gastrointestinal diseases: future therapeutic strategies, Expert Review of Clinical Pharmacology, 2010, 3, 2, 193

    CrossRef

  12. 12
    J. J. Galligan, Cannabinoid signalling in the enteric nervous system, Neurogastroenterology & Motility, 2009, 21, 9